<?xml version="1.0" encoding="UTF-8"?>
<author-notes>
 <fn fn-type="COI-statement" id="coi001">
  <p>
   <bold>Competing Interests: </bold>IBZ has received supply of the study medication from Gilead Sciences. AEG has received research funding from BioCSL Ltd, Viiv and Gilead Sciences, as well as conference travel funding and honoraria for educational presentations from Merck. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
  </p>
 </fn>
 <corresp id="cor001">* E-mail: 
  <email>Iryna.Zablotska@sydney.edu.au</email>
 </corresp>
</author-notes>
